Equities

China NT Pharma Group Company Ltd

China NT Pharma Group Company Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.025
  • Today's Change0.001 / 4.17%
  • Shares traded3.88m
  • 1 Year change-50.98%
  • Beta0.4173
Data delayed at least 15 minutes, as of May 23 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CHINA NT PHARMA GROUP COMPANY LIMITED is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in the sales and marketing of miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, as well as sub-licensing of intellectual property rights and distribution rights.

  • Revenue in HKD (TTM)7.94m
  • Net income in HKD-36.11m
  • Incorporated2010
  • Employees16.00
  • Location
    China NT Pharma Group Company LtdNo. 1 Hualing StreetSuzhou Industrial ParkSUZHOU 200020ChinaCHN
  • Phone+852 28081606
  • Fax+852 25089459
  • Websitehttp://www.ntpharma.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Global Technologies Ltd3.55m283.43k34.41m------89.079.700.000.000.000030.000080.1066--6.90--0.8516------19.87--7.99------0.3005---86.35--19.11------
Universal Health Intl Group Holding Ltd1.18bn-88.52m42.06m1.62k--0.1212--0.0357-0.1419-0.14191.840.51991.355.738.99460,614.50-10.25-25.53-22.86-33.6816.1714.18-7.58-22.510.4672-6.310.1105--1.84--43.83------
China Healthwise Holdings Ltd146.32m-134.56m48.54m100.00--11.04--0.3318-0.1746-0.17460.18990.00570.66911.5525.841,463,170.00-61.54---122.54--41.21---91.96--0.585-0.25520.9612--3.00---147.92------
Zeo Scientifix Inc36.25m-44.82m50.22m23.00------1.39-0.8249-0.82490.6729-0.24621.381.8830.66201,828.30-170.08-371.43----87.8988.28-123.65-200.710.4017-14.47-----29.7836.4321.47--40.91--
China NT Pharma Group Company Ltd7.94m-36.11m63.38m16.00------7.98-0.0183-0.07830.0038-0.13870.0115.870.337496,428.50-5.02-12.34---163.52710.06---454.67-128.280.0185--64.15-----58.1233.07---46.32--
AcuCort AB0.00-10.09m65.86m3.00--1.50-----0.2429-0.24290.000.50830.00----0.00-30.24-21.22-32.70-22.63-----------27.610.00------7.42------
Bio-Gate AG61.23m-13.70m67.57m43.00--2.37--1.10-0.1897-0.18970.84890.36461.262.1116.11168,498.80-28.61-26.98-35.93-37.8053.5259.42-22.66-21.102.13-32.010.00--20.9614.4510.20---13.30--
Pa Shun International Holdings Ltd139.57m2.53m75.22m90.0029.75--12.330.5390.00170.00170.0946-0.08490.75552.976.981,550,734.001.37-41.00---68.5122.747.031.82-61.220.27281.993.33--80.30-30.89105.42---71.41--
Bio Essence Corp4.31m-6.27m77.16m12.00------17.92-0.0223-0.0270.0156-0.04370.2621.6927.1145,959.17-38.13-46.34----50.3133.89-145.52-111.210.3017-45.505.31---11.27-10.94-52.03---48.19--
Millennium Pharmacon Internationl Tbk PT1.64bn16.15m87.08m1.15k5.390.64223.430.05325.9725.972,640.12217.992.215.725.582,914,660,000.002.181.2110.325.628.698.400.98350.52130.70851.840.7189--5.087.2035.2511.2227.63--
New Ray Medicine International Holding50.15m-22.17m90.28m23.00--0.188--1.80-0.0133-0.01330.030.28730.09731.170.36582,180,609.00-4.30-6.86-4.36-7.0722.614.24-44.20-29.8162.47--0.0006---44.13-33.0371.56---64.84--
Data as of May 23 2024. Currency figures normalised to China NT Pharma Group Company Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.